Latest updates for Apyx Medical Corporation
Fresh curated links around Apyx Medical Corporation are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity
- AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform
- Aethlon Medical reports FY results
Post angles to try
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform
Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of...
Auxano® Medical Launches Newly Redesigned Website Showcasing ARKEO™ and INTREPED® Orthopedic Implant Technologies
Redesigned website highlights proprietary Auxano® osseointegration technology and growing foot & ankle implant portfolio.
Apheon to acquire Teknimed
Teknimed is a manufacturer of orthopedic bone cements and biomaterials. The post Apheon to acquire Teknimed appeared first on PE Hub.
Peytant Solutions Names Tom Douthitt as Chief Executive Officer
Peytant Solutions, the medical technology company that developed the first and only stent covered with human-derived amniotic membrane to receive FDA De Novo granted clearance, tod...
VB Spine Signs Master Agreement with Apolo Medica
VB Spine announced that it has signed a Master Service Agreement with Apolo Medica to begin distribution of VB Spine products in Mexico.
Earnings call transcript: AngioDynamics beats Q4 2026 estimates, shares rise
Access Vascular taps Medline to help roll out new line of catheters
Access Vascular, a Massachusetts-based device maker that focuses on intravenous catheters, inked a partnership deal with medical supply giant Medline to help roll out a new line of...
Apellis Acquisition
Apellis Acquisition Anonymous (not verified) Mon, 06/22/2026 - 00:00 field_thread_url https://cafepharma.com/boards/threads/apellis-acquisition.715869/...
Pixee Medical Names Kristoff Goson CEO, Signaling Major Push for U.S. Market Growth
Kristoff Goson – Pixee Medical CAMBRIDGE, Mass., June 29, 2026 -(BUSINESS WIRE)-Today, Pixee Medical announced the appointment of…
Apnimed dreams of IPO to fund launch of sleep apnea pill on FDA's desk
Apnimed is having sweet dreams of an IPO that could fund the planned commercial launch of an obstructive sleep apnea therapy that is currently awaiting an FDA approval decision.
Apellis Acquisition
Apellis Acquisition Anonymous (not verified) Sat, 07/11/2026 - 09:12 field_thread_url https://cafepharma.com/boards/threads/apellis-acquisition.715869/...
Audax-backed Belmont Medical Technologies picks up health tech firm Arcos Inc
Belmont is a provider of fluid-resuscitation and patient-temperature management solutions. The post Audax-backed Belmont Medical Technologies picks up health tech firm Arcos Inc ap...
Pyxis Oncology: The Market Might Have Already Ruled On Micvotabart Pelidotin
Avista-backed EBI acquires Precision Medical Products’ bone healing unit Xstim
EBI is a provider of implantable and non-invasive bone growth stimulation solutions. The post Avista-backed EBI acquires Precision Medical Products’ bone healing unit Xstim appeare...
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXUâ„¢ Wound Care Program
Activities are intended to support regulatory testing and the Company’s planned first-quarter 2027 FDA 510(k) premarket notification submission
Pixee Medical Names Kristoff Goson CEO, Signaling Major Push for U.S. Market Growth
Today, Pixee Medical announced the appointment of American healthcare executive Kristoff Goson as new Chief Executive Officer.
Apogee Therapeutics, Inc. (APGE) Discusses Positive Part B Results From Phase 2 APEX Trial of Zumilokibart in Atopic Der...
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Paragon 28
Paragon 28 Anonymous (not verified) Mon, 06/08/2026 - 17:49 field_thread_url https://cafepharma.com/boards/threads/paragon-28.699211/ bo...
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.